Skip to main content
. 2010 Oct 20;30(2):639–646. doi: 10.1007/s10637-010-9565-5

Fig. 1.

Fig. 1

Plasma concentration-time profiles for sunitinib, SU12662, total drug (sunitinib + SU12662), and pemetrexed on day 1 of cycle 2 for the CDD schedule. Data are means ± standard deviation (SD) for three patients